- $49.45m
- $37.61m
- $22.67m
Intellicheck Inc expected to post a loss of 3 cents a share - Earnings Preview
Intellicheck Inc reports results for the quarter ended in September - Earnings Summary
Brief: Intellicheck Announces Third Quarter 2022 Financial Results
Intellicheck Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Intellicheck Appoints FinTech Expert And Banking Veteran To Board Of Directors
Intellicheck Inc reports results for the quarter ended in June - Earnings Summary
Brief: Intellicheck Announces Second Quarter 2022 Financial Results
Intellicheck Inc expected to post a loss of 7 cents a share - Earnings Preview
Intellicheck Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Adobe, B&G Foods, Homology Medicines
Brief: Intellicheck Announces First Quarter 2022 Financial Results
Intellicheck Inc reports results for the quarter ended in March - Earnings Summary
Intellicheck Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Intellicheck Receives Notice From The Nasdaq Stock Market Relating To Delinquent Filing Of 10-Q For The Quarter Ended March 31, 2022
Brief: Intellicheck Postpones First Quarter 2022 Earnings Report And Conference Call
Intellicheck Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Intellicheck Announces Appointment Of Jeffrey Ishmael As Chief Financial Officer
Intellicheck Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-C4 Therapeutics, Crowdstrike Holdings, Signify Health